rhenium has been researched along with Small Cell Lung Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clamon, G; Edelman, MJ; Kahn, D; Line, BR; Lister-James, J; Magram, M | 1 |
1 trial(s) available for rhenium and Small Cell Lung Carcinoma
Article | Year |
---|---|
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analog.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Oligopeptides; Organometallic Compounds; Prognosis; Radioisotopes; Radiopharmaceuticals; Receptors, Somatostatin; Rhenium; Small Cell Lung Carcinoma; Somatostatin; Survival Rate; Treatment Outcome | 2009 |